Low <i>PPP2R2A</i> expression promotes sensitivity to CHK1 inhibition in high-grade serous ovarian cancer.
Ontology highlight
ABSTRACT: Rationale: High-grade serous ovarian cancer (HGSOC), the most lethal epithelial ovarian cancer subtype, faces persistent challenges despite advances in the therapeutic use of PARP inhibitors. Thus, innovative strategies are urgently needed to improve survival rates for this deadly disease. Checkpoint kinase 1 (CHK1) is pivotal in regulating cell survival during oncogene-induced replication stress (RS). While CHK1 inhibitors (CHK1i's) show promise as monotherapy for ovarian cancer, a crucial biomarker for effective stratification in clinical trials is lacking, hindering efficacy improvement and toxicity reduction. PP2A B55α, encoded by PPP2R2A, is a regulatory subunit of the serine/threonine protein phosphatase 2 (PP2A) that influences CHK1 sensitivity in non-small cell lung c
SUBMITTER: Qiu Z
PROVIDER: S-EPMC11626944 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA